Global and China Imatinib Drug Market Insights, Forecast to 2026
Table of Contents1 Study Coverage
1.1 Imatinib Drug Product Introduction
1.2 Market Segments
1.3 Key Imatinib Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Imatinib Drug Market Size Growth Rate by Type
1.4.2 Tablets
1.4.3 Capsules
1.5 Market by Application
1.5.1 Global Imatinib Drug Market Size Growth Rate by Application
1.5.2 Chronic myelogenous leukemia
1.5.3 Gastrointestinal stromal tumors
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Imatinib Drug Market Size, Estimates and Forecasts
2.1.1 Global Imatinib Drug Revenue 2015-2026
2.1.2 Global Imatinib Drug Sales 2015-2026
2.2 Global Imatinib Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Imatinib Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Imatinib Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Imatinib Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Imatinib Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Imatinib Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Imatinib Drug Revenue Forecast by Region (2021-2026)
3 Global Imatinib Drug Competitor Landscape by Players
3.1 Global Top Imatinib Drug Sales by Manufacturers
3.1.1 Global Imatinib Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Imatinib Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Imatinib Drug Manufacturers by Revenue
3.2.1 Global Imatinib Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Imatinib Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Imatinib Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Imatinib Drug Revenue in 2019
3.2.5 Global Imatinib Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Imatinib Drug Price by Manufacturers
3.4 Global Imatinib Drug Manufacturing Base Distribution, Product Types
3.4.1 Imatinib Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Imatinib Drug Product Type
3.4.3 Date of International Manufacturers Enter into Imatinib Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Imatinib Drug Market Size by Type (2015-2020)
4.1.1 Global Imatinib Drug Sales by Type (2015-2020)
4.1.2 Global Imatinib Drug Revenue by Type (2015-2020)
4.1.3 Imatinib Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Imatinib Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Imatinib Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Imatinib Drug Revenue Forecast by Type (2021-2026)
4.2.3 Imatinib Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Imatinib Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Imatinib Drug Market Size by Application (2015-2020)
5.1.1 Global Imatinib Drug Sales by Application (2015-2020)
5.1.2 Global Imatinib Drug Revenue by Application (2015-2020)
5.1.3 Imatinib Drug Price by Application (2015-2020)
5.2 Imatinib Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Imatinib Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Imatinib Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Imatinib Drug Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Imatinib Drug Market Size YoY Growth 2015-2026
6.1.1 China Imatinib Drug Sales YoY Growth 2015-2026
6.1.2 China Imatinib Drug Revenue YoY Growth 2015-2026
6.1.3 China Imatinib Drug Market Share in Global Market 2015-2026
6.2 China Imatinib Drug Market Size by Players (International and Local Players)
6.2.1 China Top Imatinib Drug Players by Sales (2015-2020)
6.2.2 China Top Imatinib Drug Players by Revenue (2015-2020)
6.3 China Imatinib Drug Historic Market Review by Type (2015-2020)
6.3.1 China Imatinib Drug Sales Market Share by Type (2015-2020)
6.3.2 China Imatinib Drug Revenue Market Share by Type (2015-2020)
6.3.3 China Imatinib Drug Price by Type (2015-2020)
6.4 China Imatinib Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Imatinib Drug Sales Forecast by Type (2021-2026)
6.4.2 China Imatinib Drug Revenue Forecast by Type (2021-2026)
6.4.3 China Imatinib Drug Price Forecast by Type (2021-2026)
6.5 China Imatinib Drug Historic Market Review by Application (2015-2020)
6.5.1 China Imatinib Drug Sales Market Share by Application (2015-2020)
6.5.2 China Imatinib Drug Revenue Market Share by Application (2015-2020)
6.5.3 China Imatinib Drug Price by Application (2015-2020)
6.6 China Imatinib Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Imatinib Drug Sales Forecast by Application (2021-2026)
6.6.2 China Imatinib Drug Revenue Forecast by Application (2021-2026)
6.6.3 China Imatinib Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Imatinib Drug Market Size YoY Growth 2015-2026
7.2 North America Imatinib Drug Market Facts & Figures by Country
7.2.1 North America Imatinib Drug Sales by Country (2015-2020)
7.2.2 North America Imatinib Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Imatinib Drug Market Size YoY Growth 2015-2026
8.2 Europe Imatinib Drug Market Facts & Figures by Country
8.2.1 Europe Imatinib Drug Sales by Country
8.2.2 Europe Imatinib Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Imatinib Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Imatinib Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Imatinib Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Imatinib Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Imatinib Drug Market Size YoY Growth 2015-2026
10.2 Latin America Imatinib Drug Market Facts & Figures by Country
10.2.1 Latin America Imatinib Drug Sales by Country
10.2.2 Latin America Imatinib Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Imatinib Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Imatinib Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Imatinib Drug Sales by Country
11.2.2 Middle East and Africa Imatinib Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Imatinib Drug Products Offered
12.1.5 Novartis Recent Development
12.2 Glenmark Pharmaceuticals Ltd.
12.2.1 Glenmark Pharmaceuticals Ltd. Corporation Information
12.2.2 Glenmark Pharmaceuticals Ltd. Description and Business Overview
12.2.3 Glenmark Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Products Offered
12.2.5 Glenmark Pharmaceuticals Ltd. Recent Development
12.3 Sun Pharmaceuticals
12.3.1 Sun Pharmaceuticals Corporation Information
12.3.2 Sun Pharmaceuticals Description and Business Overview
12.3.3 Sun Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sun Pharmaceuticals Imatinib Drug Products Offered
12.3.5 Sun Pharmaceuticals Recent Development
12.4 Actavis Generics
12.4.1 Actavis Generics Corporation Information
12.4.2 Actavis Generics Description and Business Overview
12.4.3 Actavis Generics Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Actavis Generics Imatinib Drug Products Offered
12.4.5 Actavis Generics Recent Development
12.5 Dr. Reddy's Laboratories
12.5.1 Dr. Reddy's Laboratories Corporation Information
12.5.2 Dr. Reddy's Laboratories Description and Business Overview
12.5.3 Dr. Reddy's Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Dr. Reddy's Laboratories Imatinib Drug Products Offered
12.5.5 Dr. Reddy's Laboratories Recent Development
12.6 Teva Pharmaceutical Industries Ltd.
12.6.1 Teva Pharmaceutical Industries Ltd. Corporation Information
12.6.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
12.6.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Products Offered
12.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
12.7 Sanofi S.A.
12.7.1 Sanofi S.A. Corporation Information
12.7.2 Sanofi S.A. Description and Business Overview
12.7.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sanofi S.A. Imatinib Drug Products Offered
12.7.5 Sanofi S.A. Recent Development
12.8 Cipla Inc.
12.8.1 Cipla Inc. Corporation Information
12.8.2 Cipla Inc. Description and Business Overview
12.8.3 Cipla Inc. Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Cipla Inc. Imatinib Drug Products Offered
12.8.5 Cipla Inc. Recent Development
12.9 Apotex Inc.
12.9.1 Apotex Inc. Corporation Information
12.9.2 Apotex Inc. Description and Business Overview
12.9.3 Apotex Inc. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Apotex Inc. Imatinib Drug Products Offered
12.9.5 Apotex Inc. Recent Development
12.10 Mylan Pharms Inc.
12.10.1 Mylan Pharms Inc. Corporation Information
12.10.2 Mylan Pharms Inc. Description and Business Overview
12.10.3 Mylan Pharms Inc. Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Mylan Pharms Inc. Imatinib Drug Products Offered
12.10.5 Mylan Pharms Inc. Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Novartis Imatinib Drug Products Offered
12.11.5 Novartis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Imatinib Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Imatinib Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Imatinib Drug Market Segments
Table 2. Ranking of Global Top Imatinib Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Imatinib Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Tablets
Table 5. Major Manufacturers of Capsules
Table 6. Global Imatinib Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Imatinib Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Imatinib Drug Sales by Regions 2015-2020 (K Units)
Table 9. Global Imatinib Drug Sales Market Share by Regions (2015-2020)
Table 10. Global Imatinib Drug Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Imatinib Drug Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Imatinib Drug Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Imatinib Drug Sales Share by Manufacturers (2015-2020)
Table 14. Global Imatinib Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Imatinib Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Imatinib Drug as of 2019)
Table 16. Imatinib Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Imatinib Drug Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Imatinib Drug Price (2015-2020) (USD/Unit)
Table 19. Imatinib Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Imatinib Drug Product Type
Table 21. Date of International Manufacturers Enter into Imatinib Drug Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Imatinib Drug Sales by Type (2015-2020) (K Units)
Table 24. Global Imatinib Drug Sales Share by Type (2015-2020)
Table 25. Global Imatinib Drug Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Imatinib Drug Revenue Share by Type (2015-2020)
Table 27. Imatinib Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Imatinib Drug Sales Share by Type (2021-2026)
Table 29. Global Imatinib Drug Sales by Application (2015-2020) (K Units)
Table 30. Global Imatinib Drug Sales Share by Application (2015-2020)
Table 31. Global Imatinib Drug Sales Share by Application (2021-2026)
Table 32. Global Imatinib Drug Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Imatinib Drug Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Imatinib Drug Revenue Market Share Forecast by Application (2021-2026)
Table 35. China Imatinib Drug Sales (K Units) of Key Companies (2015-2020)
Table 36. China Imatinib Drug Sales Share by Company (2015-2020)
Table 37. China Imatinib Drug Revenue (US$ Million) by Company (2015-2020)
Table 38. China Imatinib Drug Sales (K Units) by Type (2015-2020)
Table 39. China Imatinib Drug Sales Share by Type (2015-2020)
Table 40. China Imatinib Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. China Imatinib Drug Price (K Units) by Type (2015-2020)
Table 42. China Imatinib Drug Sales (K Units) by Type (2021-2026)
Table 43. China Imatinib Drug Sales Share by Type (2021-2026)
Table 44. China Imatinib Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. China Imatinib Drug Revenue Share by Type (2021-2026)
Table 46. China Imatinib Drug Price (K Units) by Type (2021-2026)
Table 47. China Imatinib Drug Sales (K Units) by Application (2015-2020)
Table 48. China Imatinib Drug Sales Share by Application (2015-2020)
Table 49. China Imatinib Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. China Imatinib Drug Sales (K Units) by Application (2021-2026)
Table 51. China Imatinib Drug Sales Share by Application (2021-2026)
Table 52. China Imatinib Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. China Imatinib Drug Revenue Share by Application (2021-2026)
Table 54. North America Imatinib Drug Sales by Country (2015-2020) (K Units)
Table 55. North America Imatinib Drug Sales Market Share by Country (2015-2020)
Table 56. North America Imatinib Drug Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Imatinib Drug Revenue Market Share by Country (2015-2020)
Table 58. Europe Imatinib Drug Sales by Country (2015-2020) (K Units)
Table 59. Europe Imatinib Drug Sales Market Share by Country (2015-2020)
Table 60. Europe Imatinib Drug Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Imatinib Drug Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Imatinib Drug Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Imatinib Drug Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Imatinib Drug Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Imatinib Drug Revenue Market Share by Region (2015-2020)
Table 66. Latin America Imatinib Drug Sales by Country (2015-2020) (K Units)
Table 67. Latin America Imatinib Drug Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Imatinib Drug Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Imatinib Drug Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Imatinib Drug Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Imatinib Drug Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Imatinib Drug Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Imatinib Drug Revenue Market Share by Country (2015-2020)
Table 74. Novartis Corporation Information
Table 75. Novartis Description and Business Overview
Table 76. Novartis Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Novartis Imatinib Drug Product
Table 78. Novartis Recent Development
Table 79. Glenmark Pharmaceuticals Ltd. Corporation Information
Table 80. Glenmark Pharmaceuticals Ltd. Description and Business Overview
Table 81. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Glenmark Pharmaceuticals Ltd. Product
Table 83. Glenmark Pharmaceuticals Ltd. Recent Development
Table 84. Sun Pharmaceuticals Corporation Information
Table 85. Sun Pharmaceuticals Description and Business Overview
Table 86. Sun Pharmaceuticals Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Sun Pharmaceuticals Product
Table 88. Sun Pharmaceuticals Recent Development
Table 89. Actavis Generics Corporation Information
Table 90. Actavis Generics Description and Business Overview
Table 91. Actavis Generics Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Actavis Generics Product
Table 93. Actavis Generics Recent Development
Table 94. Dr. Reddy's Laboratories Corporation Information
Table 95. Dr. Reddy's Laboratories Description and Business Overview
Table 96. Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Dr. Reddy's Laboratories Product
Table 98. Dr. Reddy's Laboratories Recent Development
Table 99. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 100. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 101. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Teva Pharmaceutical Industries Ltd. Product
Table 103. Teva Pharmaceutical Industries Ltd. Recent Development
Table 104. Sanofi S.A. Corporation Information
Table 105. Sanofi S.A. Description and Business Overview
Table 106. Sanofi S.A. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Sanofi S.A. Product
Table 108. Sanofi S.A. Recent Development
Table 109. Cipla Inc. Corporation Information
Table 110. Cipla Inc. Description and Business Overview
Table 111. Cipla Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Cipla Inc. Product
Table 113. Cipla Inc. Recent Development
Table 114. Apotex Inc. Corporation Information
Table 115. Apotex Inc. Description and Business Overview
Table 116. Apotex Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Apotex Inc. Product
Table 118. Apotex Inc. Recent Development
Table 119. Mylan Pharms Inc. Corporation Information
Table 120. Mylan Pharms Inc. Description and Business Overview
Table 121. Mylan Pharms Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Mylan Pharms Inc. Product
Table 123. Mylan Pharms Inc. Recent Development
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Imatinib Drug Players
Table 128. Imatinib Drug Customers List
Table 129. Imatinib Drug Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of FiguresFigure 1. Imatinib Drug Product Picture
Figure 2. Global Imatinib Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Tablets Product Picture
Figure 4. Capsules Product Picture
Figure 5. Global Imatinib Drug Sales Market Share by Application in 2020 & 2026
Figure 6. Chronic myelogenous leukemia
Figure 7. Gastrointestinal stromal tumors
Figure 8. Others
Figure 9. Imatinib Drug Report Years Considered
Figure 10. Global Imatinib Drug Market Size 2015-2026 (US$ Million)
Figure 11. Global Imatinib Drug Sales 2015-2026 (K Units)
Figure 12. Global Imatinib Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Imatinib Drug Sales Market Share by Region (2015-2020)
Figure 14. Global Imatinib Drug Sales Market Share by Region in 2019
Figure 15. Global Imatinib Drug Revenue Market Share by Region (2015-2020)
Figure 16. Global Imatinib Drug Revenue Market Share by Region in 2019
Figure 17. Global Imatinib Drug Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Imatinib Drug Revenue in 2019
Figure 19. Imatinib Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Imatinib Drug Sales Market Share by Type (2015-2020)
Figure 21. Global Imatinib Drug Sales Market Share by Type in 2019
Figure 22. Global Imatinib Drug Revenue Market Share by Type (2015-2020)
Figure 23. Global Imatinib Drug Revenue Market Share by Type in 2019
Figure 24. Global Imatinib Drug Market Share by Price Range (2015-2020)
Figure 25. Global Imatinib Drug Sales Market Share by Application (2015-2020)
Figure 26. Global Imatinib Drug Sales Market Share by Application in 2019
Figure 27. Global Imatinib Drug Revenue Market Share by Application (2015-2020)
Figure 28. Global Imatinib Drug Revenue Market Share by Application in 2019
Figure 29. China Imatinib Drug Sales Growth Rate 2015-2026 (K Units)
Figure 30. China Imatinib Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. China Imatinib Drug Market Share in Global Market 2015-2026
Figure 32. China 5 and 10 Largest Imatinib Drug Players Market Share by Revenue in Imatinib Drug in 2019
Figure 33. China Imatinib Drug Revenue Share by Type (2015-2020)
Figure 34. China Imatinib Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 35. China Imatinib Drug Revenue Share by Application (2015-2020)
Figure 36. China Imatinib Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Imatinib Drug Sales Growth Rate 2015-2020 (K Units)
Figure 38. North America Imatinib Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Imatinib Drug Sales Market Share by Country in 2019
Figure 40. North America Imatinib Drug Revenue Market Share by Country in 2019
Figure 41. U.S. Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 42. U.S. Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 44. Canada Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Imatinib Drug Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Imatinib Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Imatinib Drug Sales Market Share by Country in 2019
Figure 48. Europe Imatinib Drug Revenue Market Share by Country in 2019
Figure 49. Germany Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 52. France Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Imatinib Drug Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Imatinib Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Imatinib Drug Sales Market Share by Region in 2019
Figure 62. Asia Pacific Imatinib Drug Revenue Market Share by Region in 2019
Figure 63. China Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Latin America Imatinib Drug Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Imatinib Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Imatinib Drug Sales Market Share by Country in 2019
Figure 88. Latin America Imatinib Drug Revenue Market Share by Country in 2019
Figure 89. Mexico Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Middle East and Africa Imatinib Drug Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Imatinib Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Imatinib Drug Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Imatinib Drug Revenue Market Share by Country in 2019
Figure 99. Turkey Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Imatinib Drug Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Imatinib Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Porter's Five Forces Analysis
Figure 106. Imatinib Drug Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed